Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 6;94(2):176-85.
doi: 10.1016/j.ajhg.2013.12.010. Epub 2014 Jan 9.

Revisiting the thrifty gene hypothesis via 65 loci associated with susceptibility to type 2 diabetes

Affiliations

Revisiting the thrifty gene hypothesis via 65 loci associated with susceptibility to type 2 diabetes

Qasim Ayub et al. Am J Hum Genet. .

Abstract

We have investigated the evidence for positive selection in samples of African, European, and East Asian ancestry at 65 loci associated with susceptibility to type 2 diabetes (T2D) previously identified through genome-wide association studies. Selection early in human evolutionary history is predicted to lead to ancestral risk alleles shared between populations, whereas late selection would result in population-specific signals at derived risk alleles. By using a wide variety of tests based on the site frequency spectrum, haplotype structure, and population differentiation, we found no global signal of enrichment for positive selection when we considered all T2D risk loci collectively. However, in a locus-by-locus analysis, we found nominal evidence for positive selection at 14 of the loci. Selection favored the protective and risk alleles in similar proportions, rather than the risk alleles specifically as predicted by the thrifty gene hypothesis, and may not be related to influence on diabetes. Overall, we conclude that past positive selection has not been a powerful influence driving the prevalence of T2D risk alleles.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Tests for Positive Selection in the Group of 64 Autosomal T2D Susceptibility Loci Tests were based on (A) the site frequency spectrum (Tajima’s D, Fay and Wu’s H, and Nielsen et al.’s CLR), (B) the composite of multiple signals (CMS), (C) haplotype diversity, or (D) population differentiation (pairwise FST) in a window of 25 kb on either side of the index SNP, except haplotype diversity, which used a window of 5 kb on each side. In each test, we examined either the combined set of loci (All) or subsets based on biological function (BF), the ancestral/derived status of the risk allele (RAS), or the effect size (ES), in each population or population pair. The results are summarized as the combined –log10 of the p value; the threshold for significance after Bonferroni correction is shown by the dotted line.
Figure 2
Figure 2
Tests for Positive Selection in the 64 Individual Autosomal T2D Susceptibility Loci Tests were based on the site frequency spectrum (Tajima’s D, Fay and Wu’s H, and Nielsen et al.’s CLR), haplotype diversity, or population differentiation (pairwise FST), and each region or each index SNP was examined separately in each population. The results are summarized as the combined –log10 of the p value; the threshold for significance after Bonferroni correction is shown by the dotted line.
Figure 3
Figure 3
Positive Selection at the NOTCH2 Locus (A) Region on chromosome 1 that spans NOTCH2 showing GENCODE (v. 14) transcript annotation (blue, protein coding transcripts; green, non-protein coding transcripts) and variant (dbSNP 137, NHLBI Exome SNPs and Indels) tracks (red, nonsynonymous and essential splice site variants; green, synonymous; black, splice site). The NHGRI GWAS Catalog track displays the position of the index SNP (rs10923931) and a highly differentiated variant (rs835574) observed between the AFR and EUR populations in the 1000 Genomes Project. The –log10p of the combined p value (boxed area) were generated from the separate probabilities of Tajima’s D, Fay and Wu’s H, and Nielsen et al.’s CLR. The threshold, represented by the dashed line, incorporates the 5% FDR for each population. Peaks above the cut-off represent regions enriched for positive selection in the CEU and CHB+JPT. (B) A closer look at the haplotype networks in a region that is in high LD (r2 ≥ 0.95) in CEU (gray area in A). Phased haplotypes were used to make the median joining networks. ENCODE annotation shows regions of open chromatin (Digital DNase I Hypersensitivity Clusters) and chromatin state segmentation in four cell lines (lymphoblastoid [GM12878], human umbilical vein endothelial [HUVEC], liver [HepG2], and human skeletal muscle myoblast [HSMM]). The region is associated with transcription and candidate enhancer regions are observed in HSMM. This is also supported by presence of binding sites for transcription factors (including IRF7) in its vicinity.
Figure 4
Figure 4
Positive Selection near HMGA2 (A) Region on chromosome 12 upstream of HMGA2 showing GENCODE (v. 14) transcript annotation (blue, protein coding transcripts; green, non-protein coding transcripts) variant (dbSNP 137) and NHGRI GWAS Catalog tracks with the index SNP (rs1531343) highlighted. ENCODE annotation shows regions of open chromatin (Digital DNase I Hypersensitivity Clusters), CpG islands, and chromatin state segmentation in four cell lines (GM12878, HUVEC, HepG2, and HSMM). The region is associated with transcription and candidate enhancer and promoter regions are observed in three cell lines. deCode Recombination Maps tracks show a male specific recombination region (blue). The –log10p of the combined p value (boxed area) show peaks above the cut-off that represent regions enriched for positive selection in the CEU. (B) A closer look at the haplotype networks in a region that is in high LD (r2 ≥ 0.95) in CEU (gray area in A). Candidate enhancer regions are observed in HUVEC and HSMM cell lines. There is a binding site for the transcription factor IRF7 in their vicinity.

References

    1. World Health Organization . WHO Press; Geneva: 2009. Global Health Risks. Mortality and Burden of Disease Attributable to Selected Major Risks.
    1. World Health Organization . WHO Press; Geneva: 2011. Global Status Report on Noncommunicable Diseases 2010.
    1. Stumvoll M., Goldstein B.J., van Haeften T.W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365:1333–1346. - PubMed
    1. Maller J.B., McVean G., Byrnes J., Vukcevic D., Palin K., Su Z., Howson J.M., Auton A., Myers S., Morris A., Wellcome Trust Case Control Consortium Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat. Genet. 2012;44:1294–1301. - PMC - PubMed
    1. Jia H., Zack M.M., Thompson W.W. The effects of diabetes, hypertension, asthma, heart disease, and stroke on quality-adjusted life expectancy. Value Health. 2013;16:140–147. - PMC - PubMed

Publication types